April 3rd, 2018
•Here we describe a protocol for employing high-throughput RNAi screening to uncover host targets that can be manipulated to enhance oncolytic virus therapy, specifically rhabodvirus and vaccinia virus therapy, but it can be readily adapted to other oncolytic virus platforms or for discovering host genes that modulate virus replication generally.
Related Videos
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved